Does having regular follow-up after surgery lead to early detection of the cancer returning, resulting in improved survival and better quality of life in patients who have had gullet or gastric cancer removal?
Not Applicable
- Conditions
- Oesophageal or gastric cancerCancer
- Registration Number
- ISRCTN14417629
- Lead Sponsor
- niversity of Oxford
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 952
Inclusion Criteria
A patient will be eligible for inclusion in this study if all of the following criteria apply:
1. Has undergone surgical resection for curatively intended treatment of oesophageal or gastric cancer (adenocarcinoma and squamous cell carcinoma) with or without neoadjuvant/adjuvant chemotherapy or radiotherapy or immunotherapy (or in combination).
2. Aged 16 years or over
3. Willing and able to give informed consent
Exclusion Criteria
A patient with not be eligible for the trial if ANY of the following apply:
1. Has other cancers undergoing treatment or surveillance for this cancer
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method All-cause mortality, defined as death from any cause. Participants who have not been observed to die during the course of the study will have their survival time censored at their last known follow-up date (evaluated at 3 years post-randomisation of the last included participant)
- Secondary Outcome Measures
Name Time Method